Point72 Europe (London) LLP Merck & Co., Inc. Transaction History
Point72 Europe (London) LLP
- $1.62 Billion
- Q4 2024
A detailed history of Point72 Europe (London) LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 11,768 shares of MRK stock, worth $1.01 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
11,768Holding current value
$1.01 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$21.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.3 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$6.91 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.24 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $217B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...